Presentations we supply
- Implant 3.6 mg
- Implant 10.8 mg
Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.
Send Enquiry for GoserelinReference information
Summarised from the product information for Zoladex 3.6 mg implant (UK product information). Always follow the product information approved in your own country.
- Active substance
- Goserelin
- Pharmacotherapeutic group
- Gonadotrophin-releasing hormone analogues (ATC code L02AE03)
- Authorised uses
- Metastatic prostate cancer
- Locally advanced prostate cancer, as an alternative to surgical castration
- High-risk localised or locally advanced prostate cancer, with radiotherapy (before or after)
- Locally advanced prostate cancer at high risk of progression, after radical prostatectomy
- Oestrogen receptor-positive early and advanced breast cancer in pre- and perimenopausal women
- Endometriosis
- Endometrial thinning before endometrial ablation or resection
- Uterine fibroids, with iron therapy, in anaemic patients before surgery
- Assisted reproduction: pituitary downregulation before superovulation
- Storage (unopened)
- Do not store above 25 °C.
- Shelf life (unopened)
- 36 months
- Container and pack
- Single-dose syringe applicator with protective sleeve
Supply from Bio Bridge Pharma
- The registration route and import licence are confirmed for your destination before we make an offer.
- Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
- Named patient supply where the destination country's rules allow it.
Sources
- Product information for Zoladex 3.6 mg implant: www.medicines.org.uk